Anixa Biosciences Inc reports results for the quarter ended in July - Earnings Summary

Anixa Biosciences

01/09/2021 22:44

* Anixa Biosciences Inc  ANIX.OQ  reported a quarterly adjusted
loss of 14 cents​​ per share for the quarter ended in July. The
lone analyst forecast for the quarter was for a loss of 8 cents
per share.
* Reported revenue was zero​;  analysts expected zero. 
* Anixa Biosciences Inc's reported EPS for the quarter was a
loss of 14 cents​.
* The mean earnings estimate of analysts had risen by
about 27.3% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Anixa Biosciences Inc shares had risen by 44.3% this
quarter and gained 82.4% so far this year.
* The company reported a quarterly loss of $4.33 million.
* Wall Street's median 12-month price target for Anixa
Biosciences Inc is $9.75 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated September 1 at 09:44 p.m.
 ​All figures in US dollars unless otherwise stated